← Leaderboards
Afonso C Silva
University Of Pittsburgh At Pittsburgh
$17,429,626
Attributed
$22,567,252
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.1M · FY2020–25$20M$15M$10M$5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$50,962,620 · 11
By mechanism
U19$36,344,804 · 7
UF1$6,850,168 · 1
R24$4,484,803 · 1
RF1$2,630,507 · 1
R01$652,338 · 1
Top collaborators
- Gregory W Carter7 shared
- Stacey J Rizzo7 shared
- Leah Byrne1 shared
- Andreas Robert Pfenning1 shared
- William Richard Stauffer1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Ann D. Cohen$26,999,530
- Tamer S Ibrahim$6,088,187
- Gulnaz Begum$2,129,850
- Howard J Aizenstein$23,319,766
- Gregg E Homanics$19,295,389
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS Disease ModelCallithrixValidationBehavioralS DiseasePathologicMultimodalityEvaluationCognitiveDisease ProgressionPhenotypeAgingGenerationsCommunitiesBioinformaticsResearch Project GrantsImageNeuropathologyBrainGenetic EngineeringProtocols DocumentationExperimental StudyEarly Onset Alzheimer Disease
Grant awards (27)
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$7,623,844
U19 · FY2025 · AG · contact PI
Multimodal Disease Characterization Core$1,730,149
U19 · FY2025 · AG · contact PI
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$524,539
U19 · FY2025 · AG · contact PI
Administrative Core$324,424
U19 · FY2025 · AG · contact PI
Project 3: Multi-modal phenotypic Characterization of marmoset models of Late Onset Alzheimer's Disease$243,658
U19 · FY2025 · AG · contact PI
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$6,287,895
U19 · FY2024 · AG · contact PI
Multimodal Disease Characterization Core$1,568,534
U19 · FY2024 · AG · contact PI
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau Seeding$1,106,921
R24 · FY2024 · AG · contact PI
Preclinical investigation of common mechanistic links between aberrant protein aggregation and blood-brain barrier dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD)$652,338
R01 · FY2024 · NS · contact PI
Administrative Core$376,991
U19 · FY2024 · AG · contact PI
U19 MARMO-AD Supplement: Resources for Marmoset Fibroblasts Conversion Pipeline$376,991
U19 · FY2024 · AG · contact PI
Administrative Core$305,833
U19 · FY2024 · AG · contact PI
Project 3: Multi-modal phenotypic Characterization of marmoset models of Late Onset Alzheimer's Disease$238,710
U19 · FY2024 · AG · contact PI
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$6,959,463
U19 · FY2023 · AG · contact PI
Multimodal Disease Characterization Core$1,305,186
U19 · FY2023 · AG · contact PI
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau Seeding$1,106,921
R24 · FY2023 · AG · contact PI
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$777,470
U19 · FY2023 · AG · contact PI
Administrative Core$305,522
U19 · FY2023 · AG · contact PI
Project 3: Multi-modal phenotypic Characterization of marmoset models of Late Onset Alzheimer's Disease$240,365
U19 · FY2023 · AG · contact PI
Cell type specific AAVs to study reward and cognition$6,850,168
UF1 · FY2022 · MH
Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease$5,845,166
U19 · FY2022 · AG · contact PI
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau Seeding$1,105,643
R24 · FY2022 · AG · contact PI
Multimodal Disease Characterization Core$753,288
U19 · FY2022 · AG · contact PI
Administrative Core$319,567
U19 · FY2022 · AG · contact PI
Project 3: Multi-modal phenotypic Characterization of marmoset models of Late Onset Alzheimer's Disease$237,209
U19 · FY2022 · AG · contact PI
Development and Validation of a Marmoset Model of Late-Onset Alzheimer Disease Based on Tau Seeding$1,165,318
R24 · FY2021 · AG · contact PI
Preclinical investigation of common mechanistic links between aberrant protein aggregation and blood-brain barrier dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD)$2,630,507
RF1 · FY2020 · NS · contact PI